Remove Avalon Remove Blogging Remove Invest Remove Startup
article thumbnail

Calporta, Started by Avalon Ventures-GSK, Is Acquired by Merck

Xconomy

Another of the biopharma startups created as part of a collaboration between San Diego investment firm Avalon Ventures and GlaxoSmithKline has been acquired—but not by GSK. Debuting in COI (which stands for “community of innovation”). Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Avalon 73
article thumbnail

After Investing, GSK to Buy Out Celiac Drug Developer Sitari Pharma

Xconomy

GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm Avalon Ventures. Avalon said Tuesday that GSK (NYSE: GSK ) has agreed to buy the company, Sitari Pharmaceuticals, which has been developing a treatment for celiac disease.

Avalon 56
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Intel Deepens Move into Sports Tech with SportStream Investment

Xconomy

ScoreStream, a five-year-old startup that created a social media platform for crowd-sourcing local sports scores, has raised $3.7 million in a Series A round that includes Intel Capital as an investor. Including the latest round, ScoreStream has raised a total of $6.8 million since it was founded in 2012.

Avalon 56
article thumbnail

Avelas Bio Raises $20M to Push Cancer-Illuminating Biologic Agent

Xconomy

Pharmstandard International, the Luxembourg-based investment arm of the Russian pharmaceutical giant Pharmstandard (and a first-time investor in Avelas), led the round. It was joined by two other new backers, Ervington Investments and Alexandria Venture Investments, and previous investors WuXi Healthcare Ventures, Bregua Corp.,

Avalon 40
article thumbnail

Plug and Play San Diego Finds Home in New Downtown Works Space

Xconomy

Plug and Play San Diego, established in 2013 as a satellite of the Sunnyvale, CA-based incubator, has funneled 15 local startups through the Silicon Valley program after providing some coaching and other services in San Diego. billion under management. Cohen described Downtown Works as a “hyper-connector.”. Downtown Works Interior.

article thumbnail

Synthorx Raises $10M to Expand Use of Synthetic DNA in Biologics

Xconomy

Synthorx, the San Diego synthetic biology startup that expanded the number of DNA base pairs with two synthetic nucleotides, said today it has raised $10 million in a Series B financing round led by RA Capital Management, the Boston life sciences hedge fund. Existing investors Avalon Ventures and Correlation Ventures joined in the round.